论文部分内容阅读
Interferon(IFN)-based therapy for hepatitis C virus(HCV)infection has recently been replaced by IFNfree direct-acting antiviral(DAA)-based therapy,which has been established as a 1st line therapy with high efficacy and tolerability due to its reasonable s